Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.45 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.41 |
| ▸ | MME | P08473 | 3/20 | 0.38 |
| ▸ | ACE | P12821 | 2/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.38 |
| ▸ | CPA1 | P15085 | 1/20 | 0.38 |
| ▸ | CTH | P32929 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
| ▸ | ECE1 | P42892 | 1/20 | 0.35 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.34 |
| ▸ | FPR2 | P25090 | 1/20 | 0.34 |
| ▸ | HMGCR | P04035 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6468862 | 0.82 | TDP1 (0.42) | TDP1ALDH1A1LMNAMAPTPTGS2 | |
| SCHEMBL8768562 | 0.80 | EGLN1 (0.42) | TDP1ALDH1A1LMNAMAPTPTGS2 | |
| SCHEMBL11403584 | 0.80 | TDP1 (0.41) | TDP1ALDH1A1LMNAMAPTPTGS2 | |
| SCHEMBL1650978 | 0.80 | EGLN1 (0.44) | TDP1ALDH1A1LMNAMAPTPTGS2 | |
| SCHEMBL8787301 | 0.78 | EGLN1 (0.43) | TDP1ALDH1A1LMNAMAPTPTGS2 | |
| Ammonia Solution, Strong SCHEMBL27685625 | 0.78 | EGLN1 (0.43) | TDP1ALDH1A1LMNAMAPTPTGS2 | |
| SCHEMBL31087129 | 0.77 | ALDH1A1 (0.42) | TDP1ALDH1A1LMNAMAPTPTGS2 | |
| SCHEMBL13448381 | 0.76 | ALDH1A1 (0.40) | TDP1ALDH1A1LMNAMAPTPTGS2 | |
| SCHEMBL29476671 | 0.76 | EGLN1 (0.41) | TDP1ALDH1A1LMNAMAPTPTGS2 | |
| SCHEMBL10786951 | 0.76 | ALDH1A1 (0.37) | TDP1ALDH1A1LMNAMAPTPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5126229-A | No background contamination | FUJI PHOTO FILM CO., LTD. (JP) | 1992-06-30 | — | — | US | claimed |
| EP-3086176-A1 | A LITHOGRAPHIC PRINTING METHOD | Fujifilm Corporation (JP) | 2016-10-26 | — | — | EP | disclosed |
| EP-3086177-A1 | METHOD FOR PREPARING A LITHOGRAPHIC PRINTING PLACE PRECURSOR | Fujifilm Corporation (JP) | 2016-10-26 | — | — | EP | disclosed |
| US-20110054212-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR AND LITHOGRAPHIC PRINTING PROCESS | OOHASHI HIDEKAZU | 2011-03-03 | — | — | US | disclosed |
| EP-1754597-B1 | Lithographic printing plate precursor and lithographic printing process | FUJIFILM CORP (JP) | 2010-12-29 | — | — | EP | disclosed |
| US-7858291-B2 | imagewise exposure, protective layer comprises water-soluble polyvinyl alcohol; phosphonium salts | FUJIFILM CORPORATION (JP) | 2010-12-28 | — | — | US | disclosed |
| US-7851126-B2 | Including an aromatic diphosphonium compound along with an addition polymerization promoter, unsaturated compound, protective layeron an sluminium support; laser recording having excellent ink receptibility during printing and printing durability; strength; on-press development; image strength | FUJIFILM CORPORATION (JP) | 2010-12-14 | — | — | US | disclosed |
| US-20070042293-A1 | Including an aromatic diphosphonium compound along with an addition polymerization promoter, unsaturated compound, protective layeron an sluminium support; laser recording having excellent ink receptibility during printing and printing durability; strength; on-press development; image strength | FUJI PHOTO FILM CO., LTD. | 2007-02-22 | — | — | US | disclosed |
| EP-1754597-A2 | Lithographic printing plate precursor and lithographic printing process | Fuji Photo Film Co., Ltd. (JP) | 2007-02-21 | — | — | EP | disclosed |
| US-20060194150-A1 | imagewise exposure, protective layer comprises water-soluble polyvinyl alcohol; phosphonium salts | FUJI PHOTO FILM CO., LTD. | 2006-08-31 | — | — | US | disclosed |
| US-5994031-A | DEVELOPMENT; WASHING | KONICA CORPORATION (JP) | 1999-11-30 | — | — | US | disclosed |
| EP-0911153-A1 | Image forming method | KONICA CORPORATION (JP) | 1999-04-28 | — | — | EP | disclosed |
| EP-0516372-B1 | Concentrated dampening water composition for lithographic printing | FUJI PHOTO FILM CO LTD (JP) | 1996-04-24 | — | — | EP | disclosed |
| US-5221330-A | Hydrophilic film-forming polymer, buffer, water miscible organic solvent, micelle-forming compound, water | FUJI PHOTO FILM CO., LTD. (JP) | 1993-06-22 | — | — | US | disclosed |
| EP-0516372-A1 | Concentrated dampening water composition for lithographic printing | FUJI PHOTO FILM CO., LTD. (JP) | 1992-12-02 | — | — | EP | disclosed |
| WO-1992019274-A1 | TECHNETIUM CHELATES TO BE USED FOR DETERMINING THE RENAL FUNCTION | MALLINCKRODT MEDICAL, INC. (US) | 1992-11-12 | — | — | WO | disclosed |
| US-5149614-A | DEVELOPER COMPOSITIONS FOR PS PLATES AND METHOD FOR DEVELOPING THE SAME WHEREIN THE DEVELOPER COMPOSITION CONTAINS A SURFACTANT HAVING AN ARYL GROUP, AN OXYALKYLENE GROUP AND A SULFATE ESTER OR SULFONIC ACID GROUP | FUJI PHOTO FILM CO., LTD. (JP) | 1992-09-22 | — | — | US | disclosed |
| US-5126229-A | No background contamination | FUJI PHOTO FILM CO., LTD. (JP) | 1992-06-30 | — | — | US | disclosed |
| US-5047309-A | Photosensitive diazonium recording material with sulfur compound containing undercoat layer | FUJI PHOTO FILM CO., LTD. (JP) | 1991-09-10 | — | — | US | disclosed |
| EP-0415422-A2 | Method for forming images | FUJI PHOTO FILM CO., LTD. (JP) | 1991-03-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054212-A1 | LITHOGRAPHIC PRINTING PLATE PRECURSOR AND LITHOGRAPHIC PRINTING PROCESS | FLNA, PFN1, FLNB | TDP1 1843/4885ALDH1A1 4285/4885LMNA 321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.